Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] Genetic engineering pharmaceuticals, genetic engineering vaccines, and

I. Company Introduction: Beijing Tri-Prime Gene Engineering Co., Ltd. (abbreviated as: Tri-Prime Gene, stock code: 920344) is a modern biomedical technology enterprise with a registered capital of RMB 121.81 million. It is mainly engaged in the research, development, production, and sales of pharmaceutical and biotechnological products, including genetically engineered pharmaceuticals, genetically engineered vaccines, and diagnostic reagents, as well as related technology trade and technical consulting services. Established in 1992, Tri-Prime Gene is an enterprise named after proprietary genetic engineering technology in China, co-founded by Mr. Hou Yunde, former Vice President of the Chinese Academy of Engineering, and Mr. Cheng Yongqing, one of China's earliest professional managers in high-tech entrepreneurship and venture capital. The main product of Tri-Prime Gene, recombinant human interferon α1b, is a first-class new drug of genetic engineering with independent intellectual property rights in China, used for the treatment of various viral diseases and malignant tumors. Yundesu (trade name of recombinant human interferon α1b) has established a high-quality brand for Chinese genetic drugs and created good economic and social benefits. Tri-Prime Gene has strong R&D capabilities. In 2001, its R&D center was approved by the Ministry of Personnel to establish a postdoctoral research workstation. Currently, it is developing more than ten projects, holds multiple new drugs in clinical research with international advanced level, and owns more than forty invention patents in China, the United States, and other countries. Tri-Prime Gene has successively undertaken more than ten major new drug innovation projects organized by the national and Beijing municipal levels and has obtained more than ten new drug certificates and production approvals. II. Corporate Honors: 1- 2017 National Science and Technology Award (awarded to Academician Hou Yunde of the company) 2- First Prize of National Science and Technology Progress Award (awarded to Academician Hou Yunde of the company) 3- High-tech Enterprise 4- Supporting unit of the "National Key Scientific and Technological Achievements Promotion Plan" 5- A-level Tax Credit Enterprise 6- Beijing Engineering Technology Research Center 7- National Life Science and Technology Talent Training Base 8- Postdoctoral Research Workstation 9- Beijing Patent Demonstration Unit 10- National Key New Product Certificate III. Management Team: Company Founder Hou Yunde: Education: 1955 - Graduated from Medical College of Tongji University, China; 1962 - Graduated from the USSR Academy of Medical Sciences with a Doctor of Medicine degree. Work Experience: 1985-1996: Director of the Institute of Virology, Chinese Academy of Preventive Medicine; Director of the WHO Collaborating Center for Virus Research in China; Director of the State Key Laboratory of Viral Gene Engineering; 1986-1996: Chief Scientist in Biotechnology of the High-Tech Development Plan of the National Science and Technology Commission; 1992-1998: Chairman of Beijing Tri-Prime Gene Engineering Co., Ltd.; 1998-present: Vice President of the Chinese Academy of Engineering, Academician; 2008-present: Chief Technical Officer for the Major Infectious Disease Project of the Ministry of Health. Company Founder and Chairman & General Manager Cheng Yongqing: Education: 1980-1984: Bachelor of Medicine in Pharmacy from West China University of Medical Sciences; 1988-1991: Master of Medicine in Biomedical Technology from Peking Union Medical College Graduate School; 1996-1998: Executive MBA from China Europe International Business School. Work Experience: 1984-1988: Deputy Director of Technology Development Department of Beijing Pharmaceutical Factory; 1990-1998: General Manager of Pharmaceutical and Biotechnology Division of China Science and Technology High-tech Investment Co., Ltd.; General Manager of France Pioneer International Co., Ltd.; 1992-2015: General Manager of Beijing Tri-Prime Gene Engineering Co., Ltd.; 2015-present: Chairman and General Manager of Beijing Tri-Prime Gene Engineering Co., Ltd. IV. Benefits: 1- Two-day weekend, social insurance plus housing fund (six insurances and one fund?) 2- Free working lunch 3- Stock options / year-end bonus 4- Trade union festival benefits, party branch activities 5- Work residence permit application 6- Free training opportunities 7- Free physical examination 8- Public rental housing application

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Tri-Prime Gene Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 北交所
  • Deal: 北交所

Tri-Prime Gene How Fast Is Hiring Growing? (9 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 32%
  • 2024: Down 9%
  • 2023: Up 13%
  • 2022: Up 100%
Tri-Prime Gene Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Tri-Prime Gene Campus Recruitment & Advanced Degree Talent Demand
Master's 1
Note: How fast is hiring at Beijing Tri-Prime Gene Engineering Co., Ltd. growing? Tri-Prime Gene2025: 21 openings (down 32%), 2024: 31 openings (down 9%), 2023: 34 openings (up 13%), 2022: 30 openings (up 100%), 2021: 15 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Tri-Prime Gene Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 150%
  • 2024: Up 300%
  • 2023: Down 50%
  • 2022: Down 67%
Tri-Prime Gene Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Beijing Tri-Prime Gene Engineering Co., Ltd. growing? Tri-Prime GeneMaster's recruitment over the years: 2025: 10 openings (up 150%), 2024: 4 openings (up 300%), 2023: 1 openings (down 50%), 2022: 2 openings (down 67%), 2021: 6 openings.

Tri-Prime Gene Doctoral Degree Job Demand Analysis

(More)
-50%
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Down 67%
  • 2023: Up 100%
  • 2022: Up 200%
Tri-Prime Gene Doctoral Hiring by Year: 2026 — 1 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Beijing Tri-Prime Gene Engineering Co., Ltd. growing? Tri-Prime GeneDoctorate recruitment over the years: 2026: 1 openings (down 50%), 2025: 2 openings (flat), 2024: 2 openings (down 67%), 2023: 6 openings (up 100%), 2022: 3 openings (up 200%), 2021: 1 openings.

Tri-Prime Gene — What Are the Salaries Like? (20 records)

Manage
Tri-Prime Gene Salary Overview
salary range: 6K - 50K, 75% of roles pay ¥10-50K
Note: salary statistics are based on 20 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Beijing Tri-Prime Gene Engineering Co., Ltd.?Tri-Prime Gene75% of positions earn 10-50K, Fresh graduate salary: ¥。经营管理类 average salary ¥34.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Tri-Prime Gene

(More)
Are salaries high at Beijing Tri-Prime Gene Engineering Co., Ltd.? We provide: 分装,车间,互联网营销,发展总监,发展经理,运营,医学联络官,发酵工程师,市场,注册部经理,药物警戒,营销专员,营销经理,财务部副经理. Click to view detailed salary analysis by job.

Tri-Prime Gene honors, qualifications & industry associations

Tri-Prime Gene Related Industry Tags

Job Category

  • 经营管理类
    52.4% of total 52.4%
  • 生物/制药/化工/环保类
    28.6% of total 28.6%
  • 贸易/物流/采购/运输类
    28.6% of total 28.6%
  • 销售类
    23.8% of total 23.8%

Education

  • 本科
    66.7% of total 66.7%
  • 硕士
    28.6% of total 28.6%
  • 博士
    4.8% of total 4.8%

Experience

  • 不限
    38.1% of total 38.1%
  • 3-5年
    23.8% of total 23.8%
  • 5-10年
    23.8% of total 23.8%
  • 1-3年
    9.5% of total 9.5%
View Detailed Analysis

What does Beijing Tri-Prime Gene Engineering Co., Ltd. require? Who is Tri-Prime Gene hiring? Tri-Prime Gene recruitment: 经营管理类占比最多占52.4%,其次是生物/制药/化工/环保类占28.6%. What education can get in at Tri-Prime Gene? 本科占比最多占66.7%,其次是硕士占28.6%. High education required at Tri-Prime Gene? 硕士占28.6%,博士占4.8%. Work experience required at Tri-Prime Gene? 不限占比最多占38.1%,其次是3-5年占23.8%. Where are the job locations at Tri-Prime Gene? 北京占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 12,181万(元)
Legal Representative: 程永庆
Date Established:
Credit Code: 91110000102851949U
Registered Address: 北京市大兴区工业开发区金苑路1号4号楼

Partners & Suppliers

公司委托其进行干扰素制剂的加工生产。 Source
供应商 药品委托生产
作为公司主要经销商,承担江苏、安徽等地的干扰素产品配送与销售。 Source
合作客户 医药分销商
作为公司主要经销商,负责华南区域干扰素产品销售。 Source
合作客户 医药分销商
作为公司主要经销商,承担华东地区干扰素产品的分销。 Source
合作客户 医药分销商
作为公司主要经销商,采购公司重组人干扰素α1b系列产品。 Source
合作客户 医药分销商

People who follow Tri-Prime Gene also follow

Tri-Prime Gene Competitors (Similar Companies)

“基因治疗药物研发商”
“Build a famous brand in the pharmaceutical packaging industry, create ”
“Life Sciences and Integrated Medicine”
工程咨询 城市规划 施工图审查 城乡规划
“Full-scenario immunodiagnostic technology platform”
医药 大健康 研发 医药科技
种猪 养猪 饲料 生猪养殖
生物科技/生物工程 干细胞 细胞治疗 细胞制备
“做强铸造装备、做大铸件生产、做精铸造服务”
“Engaged in the research and development as well as technical services ”
测序技术 肿瘤学 药物筛选 药理研究
“Brand of protein reagents for target drug development”
微电子 半导体 芯片设计 集成电路设计
生物科技/生物工程 制药/药业 生物医药 医药工业
“引正基因是一家基因编辑平台技术解决方案提供商,是基因编辑平台型技术公司,专注基因编辑工具底层技术开发。公司开发的基于CRISPR的下一代基因”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates